After a new approval and multi-million dollar deals, are ADCs finally moving to the forefront in the targeted therapy space?

Why are people still being prescribed giant tablets?

Could the pharmaceutical industry do more to prevent waste entering our water supplies?

The EMA has granted conditional marketing approval for Ervebo, the first vaccine to protect against Ebola.

With the focus on next generation bioprocessing, it is important that manufacturers do not forget to re-examine their approach to viral safety.

Step into the design space and your life will be changed forever.

Tony Hitchcock discusses his career and the evolution of the gene therapy market.

Elsevier aims to help protect patients against adverse drug reactions with its updated drug-drug interaction calculator.

What challenges are companies facing in the post-FMD climate?

Can bacterial viruses improve drug delivery to the brain?